Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+Categories
- absorbtion (3)
- active transport (2)
- ADME (4)
- antibiotics (2)
- antiviral (6)
- bioavailability (3)
- cancer (5)
- cardiotoxicity (1)
- collaboration (13)
- compound libraries (1)
- COPD (1)
- docking (13)
- drug design (8)
- drug discovery platform (1)
- druglikeness (4)
- false positive (3)
- flue (4)
- Generalized Born (15)
- GPCR (1)
- HERG (6)
- HIV (3)
- HIV-1 integrase (1)
- HSV (1)
- human neutrophil elastase (1)
- IC50 (18)
- inflammation (3)
- influenza (3)
- kinase (1)
- LD50 (2)
- logP (1)
- matrix proteins (2)
- mechanism of action exploration (2)
- MRDD (3)
- new therapeutic uses (1)
- oncology (4)
- openbabel (3)
- PDK1 (1)
- polar liquid (17)
- publications (12)
- q-Mol (1)
- QSAR (1)
- Quantum Software (11)
- RecA (1)
- scoring (1)
- selectivity (3)
- solvation energy (19)
- ss DNA (1)
- talk (5)
- toxicity (7)
- trombine (2)
- tuberculosis (4)
- Uncategorized (5)
- video (3)
- water (20)
Recent comments
- Nbarnes25 on Quantum Discovery Services
- New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1 on Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
- Anonymous on Water polarization and density profiles at a gas-liquid interface
- Anonymous on New inhibitors of RecA (bacterial SOS response system) identified.
- J G Frey on Molecular polarization on a polar liquid interface: the structure of a water surface
antiviral Archive
-
New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1
Posted on June 21, 2011 | No CommentsA key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...] -
Beefing up the pipeline: new leads against influenza virus identified
Posted on September 20, 2010 | No CommentsQuantum Free energy calculation software in combination with the docking tools and clustering tools to “zip” the amount of work required to screen the large libraries of the available chemical [...] -
Drug resistance: evolution in action
Posted on January 6, 2010 | 1 CommentIntroduction of drugs puts an evolutionary pressure on viruses and makes the viral proteins evolve. On the other hand, the change in the protein structure should be compatible with the [...] -
Quantum collaborates with University of Pittsburgh on HIV drug discovery.
Posted on October 28, 2008 | No CommentsMoscow, October, 20 2008 Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from University [...] -
Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.
Posted on May 24, 2008 | No CommentsQuantum announces a drug discovery collaboration with Tibotec Pharmaceuticals (subsidiary of Johnson & Johnson). Under the terms of the agreement Quantum will provide Tibotec Pharmaceuticals with the family of anti-viral drug [...]
![New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1 A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...]](http://q-pharm.com/wp-content/uploads/2011/06/variousvirustypes.png)
![Beefing up the pipeline: new leads against influenza virus identified Quantum Free energy calculation software in combination with the docking tools and clustering tools to “zip” the amount of work required to screen the large libraries of the available chemical [...]](http://q-pharm.com/wp-content/uploads/2010/07/influenza.png)